Tissue destruction is a far too common condition that afflicts millions each year, from victims of accidents and violence to sufferers of diseases like cancer and infection. Particle3D
aims to improve the
treatment of these patients. We are applying a patented
technology developed at the University of Southern Denmark that lets us
3D print patient fitted implants made purely from endogenous
compounds found naturally in the human body. As our implants are porous and made from endogenous
materials they convert to natural living tissues upon implantation
eliminating many of the complications that current treatments have. Due to their chemical composition, the implants can also be loaded with pharmaceuticals to combat infections and other diseases. Our technology is a platform useful for addressing both hard and soft tissue reconstruction and its performance is backed with hard science from extensive pre-clinical work including several animal trials.
Particle3D's goal is to offer the first solution that completely restores a
trauma or surgical patient's former appearance and health as if the
patient had never been sick in the first place while eliminating the complications seen with current treatments.
30. June 2017
We are very happy to announce that Particle3D won Venture Cup's National Start-Up Competition last week in Copenhagen. We are honored that we have recieved the prize and would like to thank the judges and the other participants. The event was a great experience and gave us many contacts, it also included funding for our company and a trip to meet investors in Silicon Valley. With the patients in mind that our technology could benefit, we will make sure to make the most of it to accelerate the development of our treatment platform.